Skip to main content

Sipiththa Velayuthar

Research Assistant
Matrix and Metastasis Lab

Selected Publications

See all publications
  • 2023
    Nature cancer10.1038/s43018-023-00614-y

    A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancer.

    Jessica L Chitty, Michelle Yam, Lara Perryman, Amelia L Parker, Joanna N Skhinas, Yordanos F I Setargew, Ellie T Y Mok, Emmi Tran, Rhiannon D Grant, Sharissa L Latham, Brooke A Pereira, Shona C Ritchie, Kendelle J Murphy, Michael Trpceski, Alison D Findlay, Pauline Melenec, Elysse C Filipe, Audrey Nadalini, Sipiththa Velayuthar, Gretel Major, Kaitlin Wyllie, Michael Papanicolaou, Shivanjali Ratnaseelan, Phoebe A Phillips, George Sharbeen, Janet Youkhana, Alice Russo, Antonia Blackwell, Jordan F Hastings, Morghan C Lucas, Cecilia R Chambers, Daniel A Reed, Janett Stoehr, Claire Vennin, Ruth Pidsley, Anaiis Zaratzian, Andrew M Da Silva, Michael Tayao, Brett Charlton, David Herrmann, Max Nobis, Susan J Clark, Andrew V Biankin, Amber L Johns, David R Croucher, Adnan Nagrial, Anthony J Gill, Sean M Grimmond, , , Marina Pajic, Paul Timpson, Wolfgang Jarolimek, Thomas R Cox